Carbetocin Nasal Spray for the Treatment of Hyperphagia in Prader–Willi Syndrome: Results From the Randomized, Placebo-Controlled, Phase 3 COMPASS PWS Study
Carbetocin Nasal Spray for the Treatment of Hyperphagia in Prader–Willi Syndrome: Results From the Randomized, Placebo-Controlled, Phase 3 COMPASS PWS Study. // Clinical Therapeutics. – URL: https://www.sciencedirect.com/science/article/pii/S0149291826002341?dgcid=rss_sd_all
Carbetocin Nasal Spray for the Treatment of Hyperphagia in Prader–Willi Syndrome: Results From the Randomized, Placebo-Controlled, Phase 3 COMPASS PWS Study. Clinical Therapeutics. https://www.sciencedirect.com/science/article/pii/S0149291826002341?dgcid=rss_sd_all
“Carbetocin Nasal Spray for the Treatment of Hyperphagia in Prader–Willi Syndrome: Results From the Randomized, Placebo-Controlled, Phase 3 COMPASS PWS Study.” Clinical Therapeutics.
@article{article41658,
title = {Carbetocin Nasal Spray for the Treatment of Hyperphagia in Prader–Willi Syndrome: Results From the Randomized, Placebo-Controlled, Phase 3 COMPASS PWS Study},
journal = {Clinical Therapeutics},
url = {https://www.sciencedirect.com/science/article/pii/S0149291826002341?dgcid=rss_sd_all}
}